» Articles » PMID: 38943679

Quercetin Alleviates Liver Fibrosis Via Regulating Glycolysis of Liver Sinusoidal Endothelial Cells and Neutrophil Infiltration

Overview
Journal Biomol Biomed
Date 2024 Jun 29
PMID 38943679
Authors
Affiliations
Soon will be listed here.
Abstract

Liver fibrosis, a common characteristic in various chronic liver diseases, is largely influenced by glycolysis. Quercetin (QE), a natural flavonoid known to regulate glycolysis, was studied for its effects on liver fibrosis and its underlying mechanism. In a model of liver fibrosis induced by carbon tetrachloride (CCl4), we aimed to assess pathological features, serum marker levels, and analyze the expression of glycolysis-related enzymes at both mRNA and protein levels, with a focus on changes in liver sinusoidal endothelial cells (LSECs). Our results showed that QE effectively improved liver injury and fibrosis evident by improved pathological features and lowered levels of serum markers, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), γ-glutamyl transferase (GGT), total bile acid (TBA), total bilirubin (TBIL), direct bilirubin (DBIL), hyaluronic acid (HA), laminin (LN), and procollagen type III (PCIII). QE also decreased lactate production and downregulated the expression of glycolysis-related enzymes-pyruvate kinase M2 (PKM2), phosphofructokinase platelet (PFKP), and hexokinase II (HK2)-at both the mRNA and protein levels. QE reduced the expression and activity of these enzymes, resulting in reduced glucose consumption, adenosine triphosphate (ATP) production, and lactate generation. Further analysis revealed that QE inhibited the production of chemokine (C-X-C motif) ligand 1 (CXCL1) and suppressed neutrophil recruitment. Overall, QE showed promising therapeutic potential for liver fibrosis by targeting LSEC glycolysis and reducing neutrophil infiltration.

References
1.
Kisseleva T, Brenner D . Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2020; 18(3):151-166. DOI: 10.1038/s41575-020-00372-7. View

2.
Herrero-Cervera A, Soehnlein O, Kenne E . Neutrophils in chronic inflammatory diseases. Cell Mol Immunol. 2022; 19(2):177-191. PMC: 8803838. DOI: 10.1038/s41423-021-00832-3. View

3.
Lafoz E, Ruart M, Anton A, Oncins A, Hernandez-Gea V . The Endothelium as a Driver of Liver Fibrosis and Regeneration. Cells. 2020; 9(4). PMC: 7226820. DOI: 10.3390/cells9040929. View

4.
Nevzorova Y, Weiskirchen R, Liedtke C . Mouse Models for Hepatic Stellate Cell Activation and Liver Fibrosis Initiation. Methods Mol Biol. 2023; 2669:177-191. DOI: 10.1007/978-1-0716-3207-9_10. View

5.
Zhao J, Liu Z, Chang Z . Lipopolysaccharide induces vascular endothelial cell pyroptosis via the SP1/RCN2/ROS signaling pathway. Eur J Cell Biol. 2021; 100(4):151164. DOI: 10.1016/j.ejcb.2021.151164. View